Showing results (1931-1940 of 1,951) with videos related to

Sort By:
Pageof 196
Neurology|May 9, 2008
Cell-based interventions for neurologic conditions: ethical challenges for early human trialsD J H Mathews, J Sugarman, H Bok, et al.
Biorxiv : the Preprint Server for Biology|June 19, 2024
Inhibition of the Eukaryotic Initiation Factor-2-α Kinase PERK Decreases Risk of Autoimmune Diabetes in MiceCharanya Muralidharan, Fei Huang, Jacob R Enriquez, et al.
Cerebellum (London, England)|August 12, 2022
The S-Factor, a New Measure of Disease Severity in Spinocerebellar Ataxia: Findings and ImplicationsLouisa P Selvadurai, Susan L Perlman, George R Wilmot, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|August 30, 2008
The role of animal models in evaluating reasonable safety and efficacy for human trials of cell-based interventions for neurologic conditionsAlan Regenberg, Debra J H Mathews, David M Blass, et al.
The Lancet. Child & Adolescent Health|July 6, 2026
Defining neonatal encephalopathy: an international real-time Delphi consensus processAoife Branagan, Tim Hurley, Dearbhla Byrne, et al.
Acta Neuropathologica|October 24, 2020
Brain arteriolosclerosisBrittney L Blevins, Harry V Vinters, Seth Love, et al.
Pediatric Research|June 20, 2024
Consensus definition and diagnostic criteria for neonatal encephalopathy-study protocol for a real-time modified delphi studyAoife Branagan, Tim Hurley, Fiona Quirke, et al.
Bioorganic & Medicinal Chemistry Letters|January 29, 2011
Diamide amino-imidazoles: a novel series of γ-secretase inhibitors for the treatment of Alzheimer's diseaseMichael A Brodney, David D Auperin, Stacey L Becker, et al.
Bioorganic & Medicinal Chemistry Letters|January 29, 2011
Design, synthesis, and in vivo characterization of a novel series of tetralin amino imidazoles as γ-secretase inhibitors: discovery of PF-3084014Michael A Brodney, David D Auperin, Stacey L Becker, et al.
The American Journal of Bioethics : AJOB|April 28, 2009
Unintended changes in cognition, mood, and behavior arising from cell-based interventions for neurological conditions: ethical challengesP S Duggan, A W Siegel, D M Blass, et al.
Pageof 196